PAPILLON Study - Amivantamab Chemo vs. Chemo as 1L Treatment in EGFR Exon 20 Insertion-Mutated Advanced NSCLC
PAPILLON Study - Amivantamab Chemo vs. Chemo as 1L Treatmen…
854 viewsNov 17, 2023
vumedi.com
Dr Sabari on the FDA Approval of Frontline Amivantamab Plus Chemo in EGFR Exon 20 Insertion NSCLC | OncLive
2:07
Dr Sabari on the FDA Approval of Frontline Amivantamab Plus Che…
Mar 29, 2024
onclive.com
Dr Arnold on the Evaluation of Chemo With Amivantamab or Cetuximab in RAS/BRAF Wild-Type mCRC | OncLive
Dr Arnold on the Evaluation of Chemo With Amivantamab or Cetu…
8 months ago
onclive.com
Amivantamab Accolades Add Up for NSCLC | AJMC
3:48
Amivantamab Accolades Add Up for NSCLC | AJMC
Sep 27, 2024
ajmc.com
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory EGFR-Mutated, Advanced Non-Small Cell Lung Cancer (NSCLC): Primary Results, Including Overall Survival (OS), From the Global, Phase 3, Randomized Controlled PALOMA-3 Trial | OncLive
8:58
Subcutaneous Amivantamab vs Intravenous Amivantamab, Both i…
1 week ago
onclive.com
Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutations
Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Inserti…
44 viewsMay 1, 2024
vumedi.com
Dr. Marmarelis on the Efficacy of Lazertinib/Amivantamab Plus Chemotherapy in EGFR-Mutated NSCLC | OncLive
Dr. Marmarelis on the Efficacy of Lazertinib/Amivantamab Plus Che…
2 weeks ago
onclive.com
MARIPOSA-2: Amivantamab and Chemotherapy in EGFR-Mutant N…
Dec 27, 2023
onclive.com
2021 ASCO Review on EGFR Resistance Strategies in NSCLC: …
275 viewsJul 19, 2021
vumedi.com
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mu…
Jun 19, 2024
onclive.com
Dr Girard on the Efficacy of First-Line Amivantamab Plus Chemothe…
Oct 21, 2023
onclive.com
21:25
Amivantamab Plus Chemotherapy (With or Without Lazertinib) vs Ch…
Oct 31, 2023
onclive.com
13:44
Amivantamab Plus Chemotherapy vs Chemotherapy as First-line Tre…
1 week ago
onclive.com
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
ASCO® 2024 Insights: "CHRYSALIS-2 Trial - Amivantamab Lazertinib i…
79 viewsJun 14, 2024
vumedi.com
Novel Mechanisms Set FDA-Approved Amivantamab-Lazertini…
Aug 30, 2024
ajmc.com
ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantam…
140 viewsJun 11, 2024
vumedi.com
ESMO 2024 Insights: Acquired Resistance to 1L Amivantamab + …
201 viewsOct 1, 2024
vumedi.com
6:53
Amivantamab Lazertinib in EGFR-Mutated Advanced NSCLC: Result…
Nov 14, 2023
targetedonc.com
Dr Joshua Sabari Discusses Amivantamab’s First-Line Approv…
Mar 4, 2024
ajmc.com
Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advan…
Sep 4, 2024
onclive.com
1:34
Dr Sabari on the FDA Approval of Amivantamab/Lazertinib in EGFR …
Sep 4, 2024
onclive.com
Dr Leighl on Amivantamab in Advanced NSCLC With MET Exon …
Sep 12, 2023
onclive.com
Dr Hassan on the CHRYSALIS trial of Amivantamab in EGFR Exon 20…
1 week ago
onclive.com
13:00
Amivantamab + Lazertinib Versus Osimertinib as 1L Treatment in EG…
1 week ago
onclive.com
36:21
Another Attempt at Amivantamab Stage 4 Lung Cancer Treatment. T…
4.9K viewsMar 31, 2024
FacebookJenny Appleford
30:56
7.8K views · 99 reactions | Bad Start To New Treatment ( Amivantamab...
3.5K views2 weeks ago
FacebookJenny Appleford
9:31
Nivolumab Plus Chemotherapy vs Chemotherapy as First-Line Treat…
1 week ago
onclive.com
Phase III MARIPOSA: amivantamab + lazertinib vs osimertinib in EGF…
1.9K viewsOct 22, 2023
YouTubeVJOncology
2:04
Neoadjuvant Nivolumab in Resectable Lung Cancer | NEJM
6.8K viewsMay 26, 2022
YouTubeNEJM Group
See more videos
Static thumbnail place holder